Anti-tumor necrosis factor-alpha (TNF-alpha) treatment strategies in Crohn's disease.

Recent patents on inflammation & allergy drug discovery

Volumn 1, Issue 1, 2007, Pages 21-34

  Reimund, Jean Marie ^a   Ratajczyk, Julia ^a   Sola, Brigitte ^a   Justum, Anne Marie ^a   Muller, Christian D ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; MONOCLONAL ANTIBODY; OLIGODEOXYRIBONUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ANIMAL; CROHN DISEASE; DRUG ANTAGONISM; DRUG COMBINATION; HUMAN; IMMUNOLOGY; PATENT; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DRUG THERAPY, COMBINATION; HUMANS; METHOTREXATE; OLIGODEOXYRIBONUCLEOTIDES; PATENTS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 61449309334     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221307779815093     Document Type: Review

References (167)